Dasatinib manufacturer and brief description of the drug

Dasatinib is a targeted drug that has attracted much attention in the field of modern medicine. Its original manufacturer is the internationally renowned Bristol-Myers Squibb Company. The drug is primarily used to treat certain types of leukemia, such as chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) in adults. As a tyrosine kinase inhibitor, it can effectively block abnormal signaling in cancer cells, thereby inhibiting the growth and spread of cancer cells. Its unique mechanism of action makes dasatinib excellent in the treatment of these refractory leukemias.

Patients should follow their doctor's instructions when taking dasatinib. Typically, the medication should be swallowed whole and should not be chewed or broken. The taking time generally has nothing to do with meals, but it should be taken regularly every day to ensure the stability of blood concentration. Dosage adjustments should be made according to your doctor's recommendations to ensure the effectiveness and safety of the treatment.

Although dasatinib is effective in treating leukemia, some patients may experience some adverse reactions during use. Common adverse reactions include headache, nausea, diarrhea, rash, etc. In addition, dasatinib may also cause adverse reactions in the blood system, such as thrombocytopenia, neutropenia, etc. Therefore, during use, patients should receive regular examinations from doctors to detect and deal with possible problems in a timely manner.

At present, dasatinib is officially sold in pharmacies in my country. Patients should consult themselves for the specific price. In addition to original drugs, there are also various versions of generic drugs in overseas markets, and the prices are relatively affordable. For example, the version manufactured by the Indian company NATCO is priced at only more than 500 yuan in a package of 50mg*60 tablets; the version produced by Mylan, another Indian pharmaceutical company, is priced at only more than 700 yuan in a box of 70mg*60 tablets. These generic drugs provide patients with more choices and affordability. Patients should choose according to their needs, but they must go through formal channels.